Antiretroviral therapy coverage in Portugal
Portugal: Antiretroviral therapy coverage was 82.0% in 2017. ▲ Rising
Antiretroviral therapy coverage in Portugal, 2000–2017
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in Portugal is 82.0%, measured in 2017. That is the highest value across all 18 years on record.
The figure is up 12.3% on the previous year and up 100.0% over ten years.
Over the whole period, antiretroviral therapy coverage in Portugal peaked at 82.0% in 2017 and was at its lowest, 16.0%, in 2000.
That places Portugal 45th out of 143 countries with data for 2017, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Antiretroviral therapy coverage in Portugal, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 16.0% | — |
| 2001 | 20.0% | +25.0% |
| 2002 | 24.0% | +20.0% |
| 2003 | 28.0% | +16.7% |
| 2004 | 32.0% | +14.3% |
| 2005 | 35.0% | +9.4% |
| 2006 | 38.0% | +8.6% |
| 2007 | 41.0% | +7.9% |
| 2008 | 43.0% | +4.9% |
| 2009 | 46.0% | +7.0% |
| 2010 | 51.0% | +10.9% |
| 2011 | 55.0% | +7.8% |
| 2012 | 59.0% | +7.3% |
| 2013 | 63.0% | +6.8% |
| 2014 | 67.0% | +6.3% |
| 2015 | 70.0% | +4.5% |
| 2016 | 73.0% | +4.3% |
| 2017 | 82.0% | +12.3% |
Portugal compared with similar countries
- Portugal's 82.0% is below the median for high income countries, which is 83.0%, 99% of the median. (40 countries reporting)
- Portugal's 82.0% is below the median for Europe & Central Asia, which is 83.0%, 99% of the median. (34 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 32.3% | 16.0% | 46.0% | 10 |
| 2010s | 65.0% | 51.0% | 82.0% | 8 |
Countries ranked near Portugal
- 44 Nigeria 83.0% compare
- 45 Burkina Faso 82.0% compare
- 45 Ecuador 82.0% compare
- 45 Mozambique 82.0% compare
More health data for Portugal
- Un projection of annual infant deaths, annual growth rate -2.56 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1616 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,112 deaths per 1,000 people (2090)
- Number of infants who die before age 1 38 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.39 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0199 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.15 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Portugal?
- Antiretroviral therapy coverage in Portugal was 82.0% in 2017, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Portugal?
- The highest recorded value was 82.0% in 2017.
- What is the lowest antiretroviral therapy coverage recorded in Portugal?
- The lowest recorded value was 16.0% in 2000.
- How does Portugal rank for antiretroviral therapy coverage?
- Portugal ranks 45th out of 143 countries with data for 2017.
- Is antiretroviral therapy coverage rising or falling in Portugal?
- Over the last ten years it is up 100.0%. The long-run trend across the full record is rising.
- Where does this Portugal data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.